We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+14.19%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$117B
AUM Growth
+$9.87B
Cap. Flow
-$1.11B
Cap. Flow %
-0.95%
Top 10 Hldgs %
30.52%
Holding
4,391
New
216
Increased
2,182
Reduced
1,537
Closed
202

Top Buys

Rank Stock Value
1
COF icon
Capital One
COF
+$89.2M
2
FLUT icon
Flutter Entertainment
FLUT
+$43.9M
3
OKTA icon
Okta
OKTA
+$32.1M
4
CHWY icon
Chewy
CHWY
+$31.8M
5
COIN icon
Coinbase
COIN
+$26.9M

Sector Composition

Rank Sector Weight
1 Technology 31.83%
2 Financials 13.86%
3 Consumer Discretionary 10.91%
4 Healthcare 9.41%
5 Industrials 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ELEV
3701
DELISTED
Elevation Oncology
ELEV
-78,732
Closed -$20.4K
ESTA icon
3702
Establishment Labs
ESTA
$2.21B
-682
Closed -$27.8K
FLIC
3703
DELISTED
First of Long Island Corp
FLIC
-30,986
Closed -$383K
FLL icon
3704
Full House Resorts
FLL
$86.8M
-47,962
Closed -$200K
FROG icon
3705
JFrog
FROG
$10.4B
-3,559
Closed -$114K
GALT icon
3706
Galectin Therapeutics
GALT
$316M
-16,401
Closed -$20K
GBIO
3707
DELISTED
Generation Bio
GBIO
-6,975
Closed -$28.2K
GPMT
3708
Granite Point Mortgage Trust
GPMT
$60.2M
-77,908
Closed -$203K
GPRO icon
3709
GoPro
GPRO
$107M
-183,952
Closed -$122K
GRWG icon
3710
GrowGeneration
GRWG
$89.5M
-83,886
Closed -$90.6K
HBIO icon
3711
Harvard Bioscience
HBIO
$27.6M
-4,140
Closed -$23.4K
HEES
3712
DELISTED
H&E Equipment Services
HEES
-45,551
Closed -$4.32M
HLVX
3713
DELISTED
HilleVax
HLVX
-44,294
Closed -$64.2K
HOWL icon
3714
Werewolf Therapeutics
HOWL
$18.6M
-31,231
Closed -$30.3K
IAUX
3715
i-80 Gold Corp
IAUX
$1.43B
-393,756
Closed -$229K
BRSL
3716
Brightstar Lottery PLC
BRSL
$2.07B
-169,427
Closed -$2.75M
INFU icon
3717
InfuSystem Holdings
INFU
$248M
-16,157
Closed -$86.9K
INMD icon
3718
InMode
INMD
$870M
-100,324
Closed -$1.78M
INZY
3719
DELISTED
Inozyme Pharma
INZY
-72,459
Closed -$65.9K
IPSC icon
3720
Century Therapeutics
IPSC
$372M
-43,273
Closed -$20.6K
IVVD icon
3721
Invivyd
IVVD
$203M
-79,133
Closed -$47.9K
JSPR icon
3722
Jasper Therapeutics
JSPR
$29.7M
-15,594
Closed -$67K
JWN
3723
DELISTED
Nordstrom
JWN
-274,526
Closed -$6.71M
NXDR
3724
Nextdoor Holdings
NXDR
$1.03B
-173,001
Closed -$265K
MZTI
3725
The Marzetti Company
MZTI
$3.15B
-61,695
Closed -$10.8M

Similar funds

RhumbLine Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, RhumbLine Advisers held 4,391 positions worth $117B, up 9.2% from $107B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

RhumbLine Advisers's Q2 2025 filing shows 216 new, 2,182 increased, 1,537 reduced and 202 closed positions. Its largest new stake was Ralliant Corp: 320,982 shares worth $15.6M. The largest sale was Discover Financial Services, an estimated $91M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.

  • RhumbLine Advisers's largest Q2 2025 buy was Ralliant Corp: 320,982 shares worth $15.6M.
  • RhumbLine Advisers added most to Capital One in Q2 2025, an estimated $89.2M increase.
  • RhumbLine Advisers's biggest Q2 2025 reduction was iShares Russell 2000 ETF, cutting an estimated $75.5M.
  • RhumbLine Advisers fully exited Discover Financial Services in Q2 2025, selling an estimated $91M.
  • RhumbLine Advisers's ten largest holdings make up 31% of its $117B portfolio in Q2 2025.
  • RhumbLine Advisers opened 216 new positions and closed 202 in Q2 2025.
  • RhumbLine Advisers's portfolio value rose 9.2% quarter-over-quarter to $117B.

Based on RhumbLine Advisers's 13F filing for Q2 2025, filed 12 Aug 2025.